Effects of Obesity Reduction on Cardiovascular Risk Factors: Comparison of Individual and Group Treatment - Substudy of the Croatian Healthy Weight Loss Programme

被引:0
|
作者
Jovanovic, Zeljko [3 ]
Crncevic-Orlic, Zeljka [2 ]
Stimac, Davor [2 ]
Kokic, Slaven [1 ]
Persic, Viktor [5 ]
Ruzic, Tatjana [4 ]
Goll-Baric, Sanda [3 ]
机构
[1] Univ Hosp Ctr Split, Clin Internal Med, Split 21000, Croatia
[2] Univ Hosp Ctr Rijeka, Rijeka, Croatia
[3] Healthy Weight Loss Project Rijeka, Rijeka, Croatia
[4] Psychiat Hosp Rab, Kampor, Croatia
[5] Thalasotherapia, Opatija, Croatia
关键词
cardiovascular diseases; obesity; orlistat; program evaluation; weight loss; DISEASE RISK; ORLISTAT;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Prevention of obesity may help reduce the morbidity and mortality from cardiovascular diseases. In Croatia, over half of adult population is overweight. Aldo the basic medical principles of healthy weight-loss programmes are well known, it is believed that mainly because of the leak of successful therapeutic approach obesity remains the most challenging changeable cardiovascular risk factor in nowadays clinical practice. Objective of this Croatian Healthy Weight Loss Programme substudy was to determine effects and differences between the intensive group and intensive individual weight-loss program on weight loss and cardiovascular risk factor A clinical trial included 476 adults whose body mass index (BMI) was >30 or >28 accompanied by increased blood pressure, glucose, and cholesterol. The study participants completed either a group (n = 243) or individually-based (n = 233) 6-month weight-loss program consisting of education, low-fat diet, pharmacological treatment with orlistat, psychological counselling, and exercise. Body weight, body mass index, blood pressure, blood sugar and blood cholesterol were measured in all participants after 3 and 6 months. The average weight loss was 12.2 (13%) kg and 7.6 (9%) kg in the group and individual program, respectively. Beside the weight reduction, the levels of blood cholesterol, glucose, and blood pressure were also significantly reduced in comparison with baseline, decreasing to normal values in all participants (P<0.001 for all). Decrease in the monitored parameters was greater in participants in the group program. The weight loss program provided a healthy loss of extra weight in the period of 6 months. The group program produced greater decrease in body weight, body mass index, blood pressure, glucose, and cholesterol than the individual program.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 43 条
  • [1] Efficacy of healthy weight loss program in obesity treatment: Croatian experience
    Crncevc-Orlic, Zeljka
    Jovanovic, Zeljko
    Stimac, Davor
    Zaputovic, Luka
    Persic, Viktor
    Ruzic, Alen
    COLLEGIUM ANTROPOLOGICUM, 2008, 32 (01) : 79 - 84
  • [2] Obesity, weight loss and conditional cardiovascular risk factors
    Tzotzas, T.
    Evangelou, P.
    Kiortsis, D. N.
    OBESITY REVIEWS, 2011, 12 (501) : e282 - e289
  • [3] Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
    Rössner, S
    Sjöström, L
    Noack, R
    Meinders, AE
    Noseda, G
    OBESITY RESEARCH, 2000, 8 (01): : 49 - 61
  • [4] Cardiovascular risk factors in overweight and obesity.: Changes after a weight loss treatment
    Bautista-Castaño, I
    Molina-Cabrillana, J
    Montoya-Alonso, JA
    Serra-Majem, L
    MEDICINA CLINICA, 2003, 121 (13): : 485 - 491
  • [5] Effects of weight loss on multiple cardiovascular disease risk factor reduction: One-year of treatment with orlistat.
    Lucas, C
    Hauptman, J
    Dallas, J
    Nichols, G
    Segal, KR
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 72A - 72A
  • [6] Does pharmacologically induced weight. loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors
    Finer, N
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0L) : L32 - L38
  • [7] The beneficial effects of modest weight loss on cardiovascular risk factors
    VanGaal, LF
    Wauters, MA
    DeLeeuw, IH
    INTERNATIONAL JOURNAL OF OBESITY, 1997, 21 : S5 - S9
  • [8] The role of adipokines in the improvement of diabetic and cardiovascular risk factors within a 52-week weight-loss programme for obesity
    Hausmann, Johannes
    Waechtershaeuser, Astrid
    Behnken, Imke
    Aksan, Ayseguel
    Blumenstein, Irina
    Brenner, Michael
    Loitsch, Stefan M.
    Stein, Juergen
    OBESITY RESEARCH & CLINICAL PRACTICE, 2019, 13 (05) : 440 - 447
  • [9] Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials
    Czernichow, S.
    Lee, C. M. Y.
    Barzi, F.
    Greenfield, J. R.
    Baur, L. A.
    Chalmers, J.
    Woodward, M.
    Huxley, R. R.
    OBESITY REVIEWS, 2010, 11 (02) : 150 - 158
  • [10] Improvements in cardiovascular disease risk factors associated with modest weight loss following treatment in patients with binge-eating disorder and obesity
    Yurkow, Sydney
    Ivezaj, Valentina
    Grilo, Carlos M. M.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2023, 56 (11) : 2074 - 2083